KITLG and cancer: Indeed, in cancers showing SCF expression, inhibiting the kinase activity may not be sufficient to cell death induction in tumor cells.36–39 In the biological evaluation section of this research, HCT116 cells were chosen as c-Kit positive and SCF-expressing malignant cells.